Injectable drug is designed to halt the inflammatory response and laminitis cascade of acute laminitis.

The Laminil team has put together a video it released Thursday about laminitis as it prepares to launch a crowdfunding campaign online. 

Crowdfunding is the collective effort of individuals who network and pool their money, usually via the internet, to support efforts initiated by other people or organizations.

The goal of the campaign is to raise money for Laminil to finish the Food and Drug Administration regulatory process.

Charlie Owen, the creator of the repurposed drug based in Denver, said the group is seeking $100,000 to be raised within three months, if not sooner.

"We've already heard a lot from prospective clients about how heartbreaking the video is," Owen says. "It's really moving."

The money raised would help Owen with the patent approval process and have an FDA consultant move the approval process along.

Laminil is an injectable drug designed to halt the inflammatory response and laminitis cascade of acute laminitis and active chronic laminitis. If Laminil is approved for horses, it can be sold to veterinarians.

The video shows the devastating effects of laminitis and highlights some horses that were treated with Laminil this spring and how well they are doing now.

Owen says there are no side effects and the drug has been on the market for about 25 years as an FDA-approved drug for humans.

The product is being tested around the world and major veterinary clinics.

Here's a link to the video.

For more information about Laminil, go to

What are your thoughts on this and other drugs used to treat issues with horses you've encountered?